Proteoglycan synthesis in conserved oligomeric Golgi subunit deficient HEK293T cells is affected differently, depending on the lacking subunit.

congenital disorders of glycosylation glycosaminoglycan glycosylation proteoglycans the Golgi apparatus the conserved oligomeric complex

Journal

Traffic (Copenhagen, Denmark)
ISSN: 1600-0854
Titre abrégé: Traffic
Pays: England
ID NLM: 100939340

Informations de publication

Date de publication:
07 2021
Historique:
revised: 26 05 2021
received: 25 03 2021
accepted: 27 05 2021
pubmed: 31 5 2021
medline: 3 8 2021
entrez: 30 5 2021
Statut: ppublish

Résumé

The Conserved Oligomeric Golgi (COG) complex is an eight subunit protein complex associated with Golgi membranes. Genetic defects affecting individual COG subunits cause congenital disorders of glycosylation (CDGs), due to mislocalization of Golgi proteins involved in glycosylation mechanisms. While the resulting defects in N-and O-glycosylation have been extensively studied, no corresponding study of proteoglycan (PG) synthesis has been undertaken. We here show that glycosaminoglycan (GAG) modification of PGs is significantly reduced, regardless which COG subunit that is missing in HEK293T cells. Least reduction was observed for cells lacking COG1 and COG8 subunits, that bridge the A and B lobes of the complex. Lack of these subunits did not reduce GAG chain lengths of secreted PGs, which was reduced in cells lacking any other subunit (COG2-7). COG3 knock out (KO) cells had particularly reduced ability to polymerize GAG chains. For cell-associated GAGs, the mutant cell lines, except COG4 and COG7 KO, displayed longer GAG chains than wild-type cells, indicating that COG subunits play a role in cellular turnover of PGs. In light of the important roles PGs play in animal development, the effects KO of individual COG subunits have on GAG synthesis could explain the variable severity of COG associated CDGs.

Identifiants

pubmed: 34053170
doi: 10.1111/tra.12804
pmc: PMC8382154
mid: NIHMS1732263
doi:

Substances chimiques

Adaptor Proteins, Vesicular Transport 0
Proteoglycans 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-239

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM083144
Pays : United States
Organisme : NIH HHS
ID : R01GM083144
Pays : United States
Organisme : NIH HHS
ID : R01GM083144[Correction added on 23 June 2021, after first online publication: The first author's name has been corrected from "Ravi Adusmalli" to "Ravi Adusumalli".]
Pays : United States

Informations de copyright

© 2021 The Authors. Traffic published by John Wiley & Sons Ltd.

Références

Front Cell Dev Biol. 2016 Mar 08;4:15
pubmed: 27014691
Glycobiology. 2011 Jul;21(7):853-63
pubmed: 21112967
Histochem Cell Biol. 2013 Sep;140(3):271-83
pubmed: 23839779
J Biol Chem. 2005 Aug 19;280(33):29596-603
pubmed: 15980070
Glycobiology. 2011 Dec;21(12):1554-69
pubmed: 21421995
Front Cell Dev Biol. 2019 Jul 03;7:118
pubmed: 31334232
J Cell Sci. 2017 Dec 15;130(24):4132-4143
pubmed: 29093022
J Virol. 2015 Nov 18;90(3):1414-23
pubmed: 26581979
FEBS Lett. 2016 Aug;590(15):2408-17
pubmed: 27383370
Glycobiology. 2004 Jul;14(7):599-607
pubmed: 15044385
J Biol Chem. 2001 Feb 9;276(6):3885-94
pubmed: 11110783
J Cell Sci. 2000 Jan;113 Pt 2:193-205
pubmed: 10633071
Biochem J. 1995 Nov 1;311 ( Pt 3):881-8
pubmed: 7487945
J Biol Chem. 2005 Sep 23;280(38):32736-45
pubmed: 16051600
J Med Genet. 2018 Feb;55(2):137-142
pubmed: 28848061
Traffic. 2018 Jun;19(6):463-480
pubmed: 29573151
J Biol Chem. 2002 Sep 27;277(39):36272-9
pubmed: 12138122
Cell Mol Life Sci. 2004 May;61(9):1016-24
pubmed: 15112050
Carbohydr Res. 2011 Jan 3;346(1):50-7
pubmed: 21126737
Glycobiology. 2008 Jan;18(1):53-65
pubmed: 17965432
Biomolecules. 2015 Aug 21;5(3):2003-22
pubmed: 26308067
Glycobiology. 2011 Apr;21(4):457-66
pubmed: 21062785
Traffic. 2012 Jul;13(7):891-7
pubmed: 22300173
Glycobiology. 2000 Jun;10(6):577-86
pubmed: 10814699
Biochim Biophys Acta. 2009 Sep;1792(9):896-902
pubmed: 19028570
J Cell Biol. 2005 Feb 28;168(5):747-59
pubmed: 15728195
Hum Mol Genet. 2007 Apr 1;16(7):731-41
pubmed: 17331980
J Cell Biol. 2007 Dec 3;179(5):999-1009
pubmed: 18056413
Glycobiology. 2006 Apr;16(4):326-32
pubmed: 16394120
Glycoconj J. 2013 Jan;30(1):23-31
pubmed: 22584409
Front Cell Dev Biol. 2016 Mar 30;4:23
pubmed: 27066481
Biochim Biophys Acta. 2001 Dec 19;1541(3):135-49
pubmed: 11755208
Curr Opin Struct Biol. 2018 Jun;50:144-154
pubmed: 29579579
Traffic. 2010 Dec;11(12):1552-66
pubmed: 20874812
Chem Rev. 2018 Sep 26;118(18):9152-9232
pubmed: 30204432
Hum Mol Genet. 2009 Feb 1;18(3):517-24
pubmed: 19008299
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3764-9
pubmed: 16537452
Traffic. 2009 Nov;10(11):1685-95
pubmed: 19765262
Front Neurosci. 2015 Oct 27;9:405
pubmed: 26578865

Auteurs

Ravi Adusumalli (R)

Department of Biosciences, University of Oslo, Oslo, Norway.

Hans-Christian Åsheim (HC)

Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway.

Vladimir Lupashin (V)

Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

Jessica B Blackburn (JB)

Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Department of Medicine, Division of Allergy, Vanderbilt University Medical Center, Pulmonary and Critical Care Medicine, Nashville, Tennessee, USA.

Kristian Prydz (K)

Department of Biosciences, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH